Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Accounts Payable (Quarterly): 26.79M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.79M |
| December 31, 2023 | 37.52M |
| September 30, 2023 | 18.19M |
| June 30, 2023 | 27.50M |
| March 31, 2023 | 31.49M |
| December 31, 2022 | 37.34M |
| September 30, 2022 | 14.10M |
| June 30, 2022 | 16.22M |
| March 31, 2022 | 12.27M |
| December 31, 2021 | 16.91M |
| September 30, 2021 | 4.984M |
| June 30, 2021 | 5.339M |
| March 31, 2021 | 4.158M |
| December 31, 2020 | 8.477M |
| September 30, 2020 | 11.07M |
| June 30, 2020 | 9.927M |
| March 31, 2020 | 3.078M |
| Date | Value |
|---|---|
| December 31, 2019 | 8.361M |
| September 30, 2019 | 11.84M |
| June 30, 2019 | 13.81M |
| March 31, 2019 | 11.92M |
| December 31, 2018 | 10.25M |
| September 30, 2018 | 5.469M |
| June 30, 2018 | 5.133M |
| March 31, 2018 | 4.585M |
| December 31, 2017 | 3.663M |
| September 30, 2017 | 4.001M |
| June 30, 2017 | 2.604M |
| December 31, 2016 | 2.547M |
| December 31, 2015 | 2.477M |
| September 30, 2015 | 1.268M |
| June 30, 2015 | 0.8302M |
| December 31, 2014 | 0.7515M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.078M
Minimum
Mar 2020
37.52M
Maximum
Dec 2023
15.97M
Average
13.04M
Median
Accounts Payable (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 43.80M |
| Sarepta Therapeutics Inc | 91.54M |
| Blueprint Medicines Corp | 4.926M |
| Alnylam Pharmaceuticals Inc | 78.15M |
| Cytokinetics Inc | 12.97M |